<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR26">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gallagher</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Garri</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Cain</surname>
    <given-names>EL</given-names>
   </name>
   <name>
    <surname>Ang</surname>
    <given-names>KH</given-names>
   </name>
   <name>
    <surname>Wilson</surname>
    <given-names>CG</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Hearn</surname>
    <given-names>BR</given-names>
   </name>
   <name>
    <surname>Jaishankar</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Aranda-Diaz</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Arkin</surname>
    <given-names>MR</given-names>
   </name>
  </person-group>
  <article-title>Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6Î± branch</article-title>
  <source>Elife</source>
  <year>2016</year>
  <volume>5</volume>
  <fpage>e1188e0</fpage>
  <pub-id pub-id-type="doi">10.7554/eLife.11880</pub-id>
 </element-citation>
</ref>
